Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 64

1.

Development and application of indicators for the reduction of potentially preventable hospital admissions related to medications.

Warlé-van Herwaarden MF, Valkhoff VE, Teichert M, Koffeman AR, 't Jong GW, Sturkenboom MC, De Smet PA.

Expert Opin Drug Saf. 2014 Feb;13(2):157-65. doi: 10.1517/14740338.2014.867015. Epub 2013 Dec 4.

PMID:
24304132
2.

Targeting outpatient drug safety: recommendations of the Dutch HARM-Wrestling Task Force.

Warlé-van Herwaarden MF, Kramers C, Sturkenboom MC, van den Bemt PM, De Smet PA; Dutch HARM-Wrestling Task Force..

Drug Saf. 2012 Mar 1;35(3):245-59. doi: 10.2165/11596000-000000000-00000.

PMID:
22339574
3.

Monitoring community pharmacist's quality of care: a feasibility study of using pharmacy claims data to assess performance.

Winslade N, Taylor L, Shi S, Schuwirth L, Van der Vleuten C, Tamblyn R.

BMC Health Serv Res. 2011 Jan 18;11:12. doi: 10.1186/1472-6963-11-12.

4.

Clinical medication review by a pharmacist of elderly people living in care homes--randomised controlled trial.

Zermansky AG, Alldred DP, Petty DR, Raynor DK, Freemantle N, Eastaugh J, Bowie P.

Age Ageing. 2006 Nov;35(6):586-91. Epub 2006 Aug 12.

PMID:
16905764
5.

Prescribing indicators. Development and validation of guideline-based prescribing indicators as an instrument to measure the variation in the prescribing behaviour of general practitioners.

Muijrers PE, Janknegt R, Sijbrandij J, Grol RP, Knottnerus JA.

Eur J Clin Pharmacol. 2004 Dec;60(10):739-46. Epub 2004 Oct 26.

PMID:
15517226
6.

[Risk indicators of preventable morbidity related to drug utilization].

Dago Martínez A, Arcos González P, Alvarez de Toledo Saavedra F, Baena Parejo MI, Martínez Olmos J, Gorostiza Ormaetxe I.

Gac Sanit. 2007 Jan-Feb;21(1):29-36. Spanish.

7.

Discrepancies in reported drug use in geriatric outpatients: relevance to adverse events and drug-drug interactions.

Tulner LR, Kuper IM, Frankfort SV, van Campen JP, Koks CH, Brandjes DP, Beijnen JH.

Am J Geriatr Pharmacother. 2009 Apr;7(2):93-104. doi: 10.1016/j.amjopharm.2009.04.006.

PMID:
19447362
8.

Preventing hospital admissions by reviewing medication (PHARM) in primary care: an open controlled study in an elderly population.

Leendertse AJ, de Koning GH, Goudswaard AN, Belitser SV, Verhoef M, de Gier HJ, Egberts AC, van den Bemt PM.

J Clin Pharm Ther. 2013 Oct;38(5):379-87. doi: 10.1111/jcpt.12069. Epub 2013 Apr 26.

PMID:
23617687
9.
10.

Effects of a three party healthcare network on the incidence levels of drug related problems.

Fiß T, Meinke-Franze C, van den Berg N, Hoffmann W.

Int J Clin Pharm. 2013 Oct;35(5):763-71. doi: 10.1007/s11096-013-9804-x. Epub 2013 Jul 14.

PMID:
23851929
11.

Pharmacy-specific quality indicators for asthma therapy.

Winterstein AG, Hartzema AG.

Res Social Adm Pharm. 2005 Sep;1(3):430-45.

PMID:
17138488
12.

Adverse drug events in surgical patients: an observational multicentre study.

de Boer M, Boeker EB, Ramrattan MA, Kiewiet JJ, Dijkgraaf MG, Boermeester MA, Lie-A-Huen L.

Int J Clin Pharm. 2013 Oct;35(5):744-52. doi: 10.1007/s11096-013-9797-5. Epub 2013 May 31.

PMID:
23722455
13.

Doctors' acceptance of recommendations for patients with the opportunity for pharmacotherapy improvement.

López-Montenegro Soria MA, Climente Martí M, Jiménez Torres NV.

Farm Hosp. 2011 Mar-Apr;35(2):51-7. doi: 10.1016/j.farma.2010.04.001. Epub 2010 Jul 7. English, Spanish.

PMID:
20615738
14.

Drug-related problems in the community setting: pharmacists' findings and recommendations for people with mental illnesses.

Bell JS, Whitehead P, Aslani P, McLachlan AJ, Chen TF.

Clin Drug Investig. 2006;26(7):415-25.

PMID:
17163274
15.

Characteristics of unplanned hospital admissions due to drug-related problems in cancer patients.

Chan A, Soh D, Ko Y, Huang YC, Chiang J.

Support Care Cancer. 2014 Jul;22(7):1875-81. doi: 10.1007/s00520-014-2160-0. Epub 2014 Feb 22.

PMID:
24557010
16.

A comprehensive patient safety program can significantly reduce preventable harm, associated costs, and hospital mortality.

Brilli RJ, McClead RE Jr, Crandall WV, Stoverock L, Berry JC, Wheeler TA, Davis JT.

J Pediatr. 2013 Dec;163(6):1638-45. doi: 10.1016/j.jpeds.2013.06.031. Epub 2013 Jul 30.

PMID:
23910978
17.

Implementation of medication reviews in community pharmacies and their effect on potentially inappropriate drug use in elderly patients.

Teichert M, Luijben SN, Wereldsma A, Schalk T, Janssen J, Wensing M, de Smet P.

Int J Clin Pharm. 2013 Oct;35(5):719-26. doi: 10.1007/s11096-013-9794-8. Epub 2013 May 22.

PMID:
23695593
18.

Estimating the information gap between emergency department records of community medication compared to on-line access to the community-based pharmacy records.

Tamblyn R, Poissant L, Huang A, Winslade N, Rochefort CM, Moraga T, Doran P.

J Am Med Inform Assoc. 2014 May-Jun;21(3):391-8. doi: 10.1136/amiajnl-2013-001704. Epub 2013 Aug 16.

19.

Pharmacist-based medication review reduces potential drug-related problems in the elderly: the SMOG controlled trial.

Vinks TH, Egberts TC, de Lange TM, de Koning FH.

Drugs Aging. 2009;26(2):123-33. doi: 10.2165/0002512-200926020-00004.

PMID:
19220069
20.

Application of system-level root cause analysis for drug quality and safety problems: a case study.

Sauer BC, Hepler CD.

Res Social Adm Pharm. 2013 Jan-Feb;9(1):49-59. doi: 10.1016/j.sapharm.2012.02.005. Epub 2012 May 2.

PMID:
22554397

Supplemental Content

Support Center